# Crizotinib x selumetinib x ABT-737 cytotoxicity assays
## Aim: Produce 3 or more consistent concentration/cell viability curves with crizotinib/selumetinib/ABT-737

>**[Raw data ] (../Raw_SRB_data/O6_crizotinib_selumetinib_ABT)**

### Cytotoxicity assay 1

* 14/10/19 [Day 1 - Seeding](../Daily_lab_book/LB_19-10-14.md)
* 15/10/19 [Day 2 - Drug treatment](../Daily_lab_book/LB_19-10-15.md)
* 18/10/19 [Day 5 - SRB stain](../Daily_lab_book/LB_19-10-18.md)
* 22/10/19 [Data analysis](../Daily_lab_book/LB_19-10-22.md)


### Cytotoxicity assay 2

* 17/10/19 [Day 1 - Seeding](../Daily_lab_book/LB_19-10-17.md)
* 18/10/19 [Day 2 - Drug treatment](../Daily_lab_book/LB_19-10-18.md)
* 21/10/19 [Day 5 - SRB stain](../Daily_lab_book/LB_19-10-21.md)
* 22/10/19 [Data analysis](../Daily_lab_book/LB_19-10-22.md)


### Cytotoxicity assay 3

* 21/10/19 [Day 1 - Seeding](../Daily_lab_book/LB_19-10-21.md)
* 22/10/19 [Day 2 - Drug treatment](../Daily_lab_book/LB_19-10-22.md)
* 21/10/19 [Day 5 - SRB stain] (../Daily_lab_book/LB_19-10-21.md)
* 22/10/19 [Data analysis] (../Daily_lab_book/LB_19-10-22.md)
